TCM
LMAT icon

Tekla Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Tekla Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-27,150
Closed -$642K – 197
2018
Q4 		$642K Hold
27,150
– – 0.03% 181
2018
Q3 		$1.05M Hold
27,150
– – 0.04% 182
2018
Q2 		$909K Buy
+27,150
New +$966K 0.03% 159

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tekla Capital Management's LMAT Position: Q1 2019 in Review

Tekla Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2019, closing a stake of 27,150 shares — an estimated $642K sold.

Tekla Capital Management first reported a position in LMAT in Q2 2018 and held it in 3 quarters. The position peaked at $1.05M in Q3 2018. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

  • Tekla Capital Management reported no remaining LeMaitre Vascular position as of Q1 2019 after selling out during the quarter.
  • Tekla Capital Management sold 27,150 LeMaitre Vascular shares in Q1 2019, an estimated $642K.
  • Tekla Capital Management first reported a position in LeMaitre Vascular in Q2 2018 and held it in 3 quarters.
  • Tekla Capital Management's LeMaitre Vascular position peaked at $1.05M in Q3 2018.
  • 155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Tekla Capital Management's 13F filing for Q1 2019, filed 14 May 2019.